1. Home
  2. BDC vs BLCO Comparison

BDC vs BLCO Comparison

Compare BDC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$113.76

Market Cap

5.6B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.32

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
BLCO
Founded
1902
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Ophthalmic Goods
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.9B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
BDC
BLCO
Price
$113.76
$16.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$162.50
$18.45
AVG Volume (30 Days)
351.2K
378.4K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
0.16%
N/A
EPS Growth
23.13
N/A
EPS
1.30
N/A
Revenue
$2,715,194,000.00
$5,101,000,000.00
Revenue This Year
$8.91
$8.65
Revenue Next Year
$4.70
$5.59
P/E Ratio
$86.95
N/A
Revenue Growth
10.33
6.47
52 Week Low
$102.49
$10.83
52 Week High
$159.99
$18.92

Technical Indicators

Market Signals
Indicator
BDC
BLCO
Relative Strength Index (RSI) 32.72 51.18
Support Level $111.12 $16.26
Resistance Level $123.62 $17.11
Average True Range (ATR) 4.97 0.47
MACD -1.81 -0.02
Stochastic Oscillator 7.53 56.18

Price Performance

Historical Comparison
BDC
BLCO

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: